BioEximi OÜRegistered
Key figures
2 176 753 €+9,7%
Revenue 2025
+23,3%
Average annual growth 2019–2025
Ratios
2025−1,7%
Profit margin
0,5%
EBITDA margin
−6,2%
Equity ratio
0,8×
Current ratio
107,7%
Return on equity
1823 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 73 010 € | 36 | 102 084 € |
| Q1 2026 | 76 287 € | 35 | 93 477 € |
| Q4 2025 | 105 919 € | 36 | 105 118 € |
| Q3 2025 | 74 595 € | 33 | 104 034 € |
| Q2 2025 | 68 172 € | 34 | 98 202 € |
| Q1 2025 | 64 338 € | 34 | 94 620 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
No dividends were distributed.
History
20250 €
20240 €
20230 €
20220 €
2021 ~908 056 €
20200 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 829 080 | 1 012 731 | 169 103 | 260 283 | 337 615 | 444 328 | 466 878 |
| Total non-current assets | 0 | 93 674 | 207 299 | 202 191 | 158 185 | 114 668 | 87 070 |
| Total assets | 829 080 | 1 106 405 | 376 402 | 462 474 | 495 800 | 558 996 | 553 948 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 71 980 | 265 024 | 579 934 | 388 553 | 516 152 | 626 360 | 588 045 |
| Non-current liabilities | 0 | 54 182 | 38 747 | 128 446 | 124 324 | 0 | — |
| Total liabilities | 71 980 | 319 206 | 618 681 | 516 999 | 640 476 | 626 360 | 588 045 |
| Share capital | 2560 | 2560 | 2560 | 2560 | 2560 | 2560 | 2560 |
| Retained earnings of previous periods | 530 724 | 754 284 | −123 673 | −245 095 | −482 341 | −628 491 | −672 830 |
| Profit for the year | 223 560 | 30 099 | −121 422 | −237 246 | −146 151 | −44 338 | −36 732 |
| Reserves and other equity | 256 | 256 | 256 | 425 256 | 481 256 | 602 905 | 672 905 |
| Total equity | 757 100 | 787 199 | −242 279 | −54 525 | −144 676 | −67 364 | −34 097 |
| Income statement | |||||||
| Sales revenue | 619 909 | 683 161 | 1 054 278 | 1 255 148 | 1 601 558 | 1 985 004 | 2 176 753 |
| Operating profit | 203 726 | 10 057 | −108 698 | −223 866 | −132 020 | −31 780 | −30 422 |
| EBITDA | 203 726 | 11 710 | −71 578 | −183 251 | −89 573 | 11 250 | 10 197 |
| Profit before income tax | 223 560 | 30 099 | −121 422 | −237 246 | −146 151 | −44 338 | −36 732 |
| Profit for the reporting year | 223 560 | 30 099 | −121 422 | −237 246 | −146 151 | −44 338 | −36 732 |
| Labour costs | 203 244 | 297 144 | 373 029 | 556 688 | 627 124 | 791 110 | 875 855 |
| Depreciation of non-current assets | 0 | 1653 | 37 120 | 40 615 | 42 447 | 43 030 | 40 619 |
| Other indicators | |||||||
| Employees | 13 | 11 | 13 | 13 | 13 | 17 | 18 |
| Calculated dividend | — | 0 | 908 056 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Related companies
Same activity — Other human health activities n.e.c.